FDA
approval
· 2023-12-15
FDA Approved: BUPRENORPHINE — Supplemental Application (Actavis Pharma, Inc.)
Summary
The FDA approved a supplemental application for buprenorphine from Actavis Pharma, Inc. The action indicates an additional approval under an Abbreviated New Dru…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)